Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
RSNA 2020 is in the books, but that does not mean coverage on Diagnostic Imaging stops. The conference still has a great deal to offer. Later this week, look for the third, and final, installment of videos with David Larson, M.D., professor of radiology at Stanford University, focusing on the ethical questions and challenges surrounding the use of artificial intelligence with patient data and medical imaging.
For the previous two videos with Larson, as well as other RSNA 2020 coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
As the country rounds into the holidays and toward the New Year, cases of COVID-19 are, once again, surging. That makes it all the more critical for providers to be able to identify patients who are infected with the virus and, potentially, learn who will fare better or worse. New research is out this week focusing on this issue – Diagnostic Imaging will report on the role imaging plays later this week.
For additional reporting on the use of imaging to diagnose and assess COVID-19 patients, click here.
Since March, 2020 has been a rough, demanding year, putting radiology in the middle of the worst healthcare crisis seen in a century. But, dealing with the pandemic is not the only health-related event throughout the past 12 months. While radiologists and other healthcare providers were focused on the emergent needs, advancements were still marching on in other areas of medical imaging. This week, Diagnostic Imaging will share some the biggest developments of the year in mammography.
For additional mammography coverage, click here.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.